CVE-2026-18683

CVE-2026-18683 is a high-severity vulnerability in Ibm I with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM i 7.6, 7.5, 7.4, and 7.3 is vulnerable to privilege escalation via Navigator for i. An authenticated user could elevate privileges to a root user to execute commands.

Frequently asked questions

What is CVE-2026-18683?
IBM i 7.6, 7.5, 7.4, and 7.3 is vulnerable to privilege escalation via Navigator for i. An authenticated user could elevate privileges to a root user to execute commands.
How severe is CVE-2026-18683?
CVE-2026-18683 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-18683 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (54th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-18683?
CVE-2026-18683 primarily affects Ibm I. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-18683?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-18683 published?
CVE-2026-18683 was published on 2026-08-12 and last updated on 2026-08-17.

References

Affected products (4)

More vulnerabilities in Ibm I

All CVEs affecting Ibm I →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →